QQ客服 官方微博 反馈留言

	Screening of illegally adulterated 1,4-dihydropyridine calcium antagonists in traditional Chinese medicines by a high-performance liquid chromatography electrospray ionization in-source collision-induced dissociation triple quadrupole mass spectrometric
	Yang Minghua[1]; Zhang Fang[2]; Hou Yuting[3]; Su Yue[4]; Guo Yinlong[5]
刊名	Rapid communications in mass spectrometry : RCM
	2018
卷号	32页码:672-676
ISSN号	1097-0231
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2180864
专题	上海大学
作者单位	1.Center for Chinese Medicine Therapy and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. 2.National Center for Organic Mass Spectrometry in Shanghai, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 200032, China. 3.Guanghua Integrative Medicine Hospital, Shanghai, 200052, China.
推荐引用方式 GB/T 7714	Yang Minghua[1],Zhang Fang[2],Hou Yuting[3],et al. Screening of illegally adulterated 1,4-dihydropyridine calcium antagonists in traditional Chinese medicines by a high-performance liquid chromatography electrospray ionization in-source collision-induced dissociation triple quadrupole mass spectrometric[J]. Rapid communications in mass spectrometry : RCM,2018,32:672-676.
APA	Yang Minghua[1],Zhang Fang[2],Hou Yuting[3],Su Yue[4],&Guo Yinlong[5].(2018).Screening of illegally adulterated 1,4-dihydropyridine calcium antagonists in traditional Chinese medicines by a high-performance liquid chromatography electrospray ionization in-source collision-induced dissociation triple quadrupole mass spectrometric.Rapid communications in mass spectrometry : RCM,32,672-676.
MLA	Yang Minghua[1],et al."Screening of illegally adulterated 1,4-dihydropyridine calcium antagonists in traditional Chinese medicines by a high-performance liquid chromatography electrospray ionization in-source collision-induced dissociation triple quadrupole mass spectrometric".Rapid communications in mass spectrometry : RCM 32(2018):672-676.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。